Ganfeng Lithium Group Co., Ltd.

OTCPK:GNEN.F Stock Report

Market Cap: US$10.1b

Ganfeng Lithium Group Valuation

Is GNEN.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GNEN.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GNEN.F ($3.04) is trading above our estimate of fair value ($0.35)

Significantly Below Fair Value: GNEN.F is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for GNEN.F?

Key metric: As GNEN.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for GNEN.F. This is calculated by dividing GNEN.F's market cap by their current revenue.
What is GNEN.F's PS Ratio?
PS Ratio3.8x
SalesCN¥21.21b
Market CapCN¥73.07b

Price to Sales Ratio vs Peers

How does GNEN.F's PS Ratio compare to its peers?

The above table shows the PS ratio for GNEN.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.7x
SQM Sociedad Química y Minera de Chile
2.3x12.0%US$11.1b
ALB Albemarle
1.9x9.1%US$12.9b
AXTA Axalta Coating Systems
1.7x3.0%US$9.0b
CE Celanese
0.8x2.3%US$8.4b
GNEN.F Ganfeng Lithium Group
3.8x14.3%US$73.1b

Price-To-Sales vs Peers: GNEN.F is expensive based on its Price-To-Sales Ratio (3.8x) compared to the peer average (1.7x).


Price to Sales Ratio vs Industry

How does GNEN.F's PS Ratio compare vs other companies in the US Chemicals Industry?

12 CompaniesPrice / SalesEstimated GrowthMarket Cap
TSE Trinseo
0.04x5.0%US$134.17m
ALTO Alto Ingredients
0.1x3.1%US$107.31m
CGA Enlightify
0.3xn/aUS$29.29m
BON Bon Natural Life
0.3xn/aUS$6.71m
GNEN.F 3.8xIndustry Avg. 1.4xNo. of Companies15PS01.22.43.64.86+
12 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: GNEN.F is expensive based on its Price-To-Sales Ratio (3.8x) compared to the US Chemicals industry average (1.4x).


Price to Sales Ratio vs Fair Ratio

What is GNEN.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GNEN.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio3.8x
Fair PS Ratio1.3x

Price-To-Sales vs Fair Ratio: GNEN.F is expensive based on its Price-To-Sales Ratio (3.8x) compared to the estimated Fair Price-To-Sales Ratio (1.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies